13.36
3.95%
-0.55
Handel nachbörslich:
13.36
Ginkgo Bioworks Holdings Inc Aktie (DNA) Neueste Nachrichten
Ginkgo Bioworks (NYSE:DNA) Trading Down 6.3%Time to Sell? - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Trading 9.7% HigherWhat's Next? - MarketBeat
Ginkgo Bioworks (DNA) Upgraded to Strong Buy: Here's What You Should Know - MSN
Vanguard Group Inc Reduces Stake in Ginkgo Bioworks Holdings Inc - GuruFocus.com
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Moves -0.24%: What You Should Know - MSN
Ginkgo Bioworks: Declining Core Revenue And High Cash Burn Echo Amyris' Path (NYSE:DNA) - Seeking Alpha
Africa CDC and Ginkgo Bioworks Announce Collaboration to Strengthen Laboratory Network Capacity Across African Union Member States - Marketscreener.com
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Stock Position Reduced by Exchange Traded Concepts LLC - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Shares Gap DownWhat's Next? - MarketBeat
Ginkgo (DNA) to Report Q2 Earnings: What's in the Cards? - MSN
Is BioLife Solutions (BLFS) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by Barclays PLC - MarketBeat
Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC) - Marketscreener.com
Ginkgo Bioworks Secures Major Lab Automation Contract with DOE Research Center at UW-Madison - StockTitan
Ginkgo Bioworks (NYSE:DNA) Trading Up 6.4%What's Next? - MarketBeat
SaponiQx, Probius, and Ginkgo Bioworks Unite to Revolutionize Vaccine Adjuvant Development - Marketscreener.com
Ginkgo Bioworks (NYSE:DNA) Trading 9.1% HigherStill a Buy? - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Shares Gap UpStill a Buy? - MarketBeat
DNAGinkgo Bioworks Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors - PR Newswire
Ginkgo Bioworks Partners with Astellas' Universal Cells to Advance Cancer Cell Therapy Innovation - StockTitan
Ginkgo Bioworks (NYSE:DNA) Stock Price Down 9.1%What's Next? - MarketBeat
(DNA) On The My Stocks Page - Stock Traders Daily
Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference - PR Newswire
Barclays PLC Trims Stock Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks officer sells stock for $3,796 By Investing.com - Investing.com Canada
Ginkgo Bioworks officer sells stock for $3,796 - Investing.com India
Ginkgo Bioworks (NYSE:DNA) Trading 6.5% HigherHere's Why - MarketBeat
Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Geode Capital Management LLC Trims Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by State Street Corp - MarketBeat
(DNA) Trading Advice - Stock Traders Daily
Ginkgo Bioworks (NYSE:DNA) Stock Price Down 7.9%Here's Why - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Shares Down 6.6%Here's What Happened - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 1,865,335 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Stock Price Up 4.1%What's Next? - MarketBeat
Teachers Retirement System of The State of Kentucky Cuts Stock Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
All You Need to Know About Ginkgo Bioworks (DNA) Rating Upgrade to Buy - MSN
Ginkgo Bioworks joins project on cell-based disease treatment By Investing.com - Investing.com South Africa
Ginkgo Bioworks joins project on cell-based disease treatment - Investing.com
Ginkgo Bioworks Lands $9.4M Contract for Groundbreaking Bioelectronic Treatment Technology - StockTitan
Charles Schwab Investment Management Inc. Decreases Stock Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Investors Get Final OK Of $17.8M Settlement - Law360
Janus Henderson Group PLC Has $118,000 Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo to Pay $17.8 Million in Class Deal Over SPAC Merger, IPO - Bloomberg Law
Ginkgo Bioworks (NYSE:DNA) Trading Down 5.5%What's Next? - MarketBeat
Verition Fund Management LLC Takes Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Lowers Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):